Transplant International is looking for its publishing partner
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer – Open for comments until 06 April
This pre-print from TLJ 2.0 WS03 on ‘Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancer’ is now open for comments on Transplant Live....
Scientific Highlights – Transplantation Learning Journey TLJ 2.0
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of...
Exploring the adaptation of patients after heart transplantation
Great to see this article for Open Access Government from Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of our ETAHP...
EKHA Open Letter to EU Policymakers
EKHA Open Letter to EU Policymakers On Behalf Of The European Organ Donation and Transplantation Community “Life After Covid-19: Time to realise a Second...
Important outcomes from ESOT TLJ 2.0 highlighted in Lancet
It is highly encouraging to see important outcomes from ESOT TLJ 2.0 highlighted in this article from The Lancet Medical Journal, exploring why people...
ELPAT Board – 2021 Call for nominations: Vice-Chair
ELPAT, the ESOT Section focusing on the Ethical, Legal and Psychosocial Aspects of organ Transplantation, invites nominations for the position of Vice-Chair (2021-2024). At...
ESOT Congress 2021 – Submit your abstract next week and receive feedback!
ESOT is pleased to announce a new initiative in collaboration with the Centre for Evidence in Transplantation (CET), allowing 40 prospective abstract submitters to...
In memoriam -Duška Dragun (1969-2020)
We deeply mourn the passing of our colleague Prof. Duska Dragun, who died on 28th of December 2020 in Berlin at the age of...
